 Ian Brooks
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Data Warehousing | 1 | 2022 | 6 | 0.820 |
Why?
| | Cloud Computing | 1 | 2022 | 8 | 0.820 |
Why?
| | Community Pharmacy Services | 1 | 2018 | 45 | 0.620 |
Why?
| | Health Communication | 1 | 2018 | 41 | 0.620 |
Why?
| | Research Personnel | 2 | 2009 | 154 | 0.580 |
Why?
| | Reminder Systems | 1 | 2018 | 162 | 0.560 |
Why?
| | Pharmacists | 1 | 2018 | 235 | 0.540 |
Why?
| | Telemedicine | 1 | 2018 | 667 | 0.360 |
Why?
| | A Kinase Anchor Proteins | 1 | 2010 | 65 | 0.350 |
Why?
| | Receptors, AMPA | 1 | 2010 | 120 | 0.340 |
Why?
| | Protein Kinase C | 2 | 2010 | 274 | 0.340 |
Why?
| | Competitive Behavior | 1 | 2009 | 39 | 0.340 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 158 | 0.320 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2008 | 9 | 0.310 |
Why?
| | Career Mobility | 1 | 2008 | 64 | 0.300 |
Why?
| | Publishing | 1 | 2009 | 126 | 0.300 |
Why?
| | Medication Errors | 1 | 2008 | 89 | 0.290 |
Why?
| | Text Messaging | 2 | 2020 | 154 | 0.290 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 789 | 0.250 |
Why?
| | Pain | 2 | 2008 | 713 | 0.250 |
Why?
| | Medical Informatics | 2 | 2020 | 94 | 0.230 |
Why?
| | Patient-Centered Care | 1 | 2008 | 475 | 0.210 |
Why?
| | Information Dissemination | 1 | 2023 | 192 | 0.190 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 785 | 0.180 |
Why?
| | Crowdsourcing | 1 | 2020 | 16 | 0.180 |
Why?
| | Interinstitutional Relations | 1 | 2020 | 55 | 0.180 |
Why?
| | Signal Transduction | 2 | 2010 | 4526 | 0.180 |
Why?
| | Precision Medicine | 1 | 2024 | 356 | 0.180 |
Why?
| | World Health Organization | 1 | 2020 | 105 | 0.170 |
Why?
| | Hernia, Hiatal | 1 | 2019 | 32 | 0.170 |
Why?
| | Herniorrhaphy | 1 | 2019 | 51 | 0.170 |
Why?
| | Cell Phone Use | 1 | 2018 | 2 | 0.160 |
Why?
| | Mentoring | 1 | 2020 | 103 | 0.160 |
Why?
| | Bacterial Infections | 1 | 2000 | 222 | 0.150 |
Why?
| | Anemia | 1 | 2019 | 144 | 0.150 |
Why?
| | Sinusitis | 1 | 2000 | 175 | 0.150 |
Why?
| | Patient Care | 1 | 2018 | 103 | 0.150 |
Why?
| | Social Media | 1 | 2020 | 135 | 0.150 |
Why?
| | Health Education | 1 | 2020 | 317 | 0.150 |
Why?
| | Betacoronavirus | 1 | 2020 | 253 | 0.140 |
Why?
| | Transition to Adult Care | 1 | 2017 | 60 | 0.140 |
Why?
| | Pandemics | 2 | 2022 | 1333 | 0.130 |
Why?
| | Ice | 1 | 2015 | 19 | 0.130 |
Why?
| | Diabetes Mellitus | 2 | 2020 | 906 | 0.130 |
Why?
| | Patient Participation | 1 | 2018 | 362 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 343 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 335 | 0.120 |
Why?
| | Neurons | 3 | 2013 | 1301 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2020 | 486 | 0.120 |
Why?
| | Atmosphere | 1 | 2015 | 89 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 221 | 0.120 |
Why?
| | Chronic Disease | 1 | 2020 | 1602 | 0.120 |
Why?
| | Medication Adherence | 1 | 2018 | 536 | 0.110 |
Why?
| | United States | 4 | 2022 | 12338 | 0.110 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2013 | 101 | 0.100 |
Why?
| | Tyrosine | 1 | 2013 | 218 | 0.100 |
Why?
| | Endocytosis | 1 | 2013 | 152 | 0.100 |
Why?
| | Quality of Life | 2 | 2020 | 2392 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 182 | 0.100 |
Why?
| | Humans | 16 | 2024 | 115908 | 0.090 |
Why?
| | Phosphorylation | 2 | 2013 | 1561 | 0.090 |
Why?
| | Hippocampus | 2 | 2013 | 710 | 0.090 |
Why?
| | Clinical Laboratory Information Systems | 1 | 2009 | 6 | 0.090 |
Why?
| | Medical Informatics Applications | 1 | 2009 | 9 | 0.080 |
Why?
| | Drug Interactions | 2 | 2008 | 347 | 0.080 |
Why?
| | Professional Practice | 1 | 2009 | 62 | 0.080 |
Why?
| | Enzyme Activation | 1 | 2010 | 791 | 0.080 |
Why?
| | Diffusion of Innovation | 1 | 2009 | 94 | 0.080 |
Why?
| | Education, Graduate | 1 | 2008 | 32 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2010 | 604 | 0.080 |
Why?
| | Gemfibrozil | 1 | 2008 | 10 | 0.080 |
Why?
| | Carbamates | 1 | 2008 | 35 | 0.080 |
Why?
| | Congresses as Topic | 1 | 2009 | 200 | 0.080 |
Why?
| | Hypolipidemic Agents | 1 | 2008 | 87 | 0.070 |
Why?
| | Multicenter Studies as Topic | 1 | 2008 | 249 | 0.070 |
Why?
| | Clinical Trials as Topic | 2 | 2009 | 945 | 0.070 |
Why?
| | Piperidines | 1 | 2008 | 163 | 0.070 |
Why?
| | Cations | 1 | 2005 | 78 | 0.060 |
Why?
| | TRPV Cation Channels | 1 | 2005 | 28 | 0.060 |
Why?
| | Extracellular Space | 1 | 2005 | 121 | 0.060 |
Why?
| | Software | 1 | 2008 | 532 | 0.060 |
Why?
| | Adult | 5 | 2022 | 30820 | 0.060 |
Why?
| | Louisiana | 1 | 2023 | 24 | 0.060 |
Why?
| | Indiana | 1 | 2023 | 27 | 0.060 |
Why?
| | Hospital Mortality | 1 | 2008 | 784 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 101 | 0.050 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 686 | 0.050 |
Why?
| | Time Factors | 2 | 2009 | 6186 | 0.050 |
Why?
| | Biomedical Research | 1 | 2007 | 590 | 0.050 |
Why?
| | Meaningful Use | 1 | 2020 | 11 | 0.050 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1008 | 0.050 |
Why?
| | Drug Resistance, Microbial | 1 | 2000 | 66 | 0.040 |
Why?
| | Hyperlipidemias | 1 | 2020 | 123 | 0.040 |
Why?
| | Genomics | 1 | 2024 | 641 | 0.040 |
Why?
| | Mutagenesis | 2 | 2013 | 171 | 0.040 |
Why?
| | Blood Glucose | 1 | 2008 | 1826 | 0.040 |
Why?
| | Patch-Clamp Techniques | 2 | 2013 | 245 | 0.040 |
Why?
| | Electric Stimulation | 2 | 2013 | 263 | 0.040 |
Why?
| | Machine Learning | 1 | 2022 | 319 | 0.040 |
Why?
| | Medical Records Systems, Computerized | 2 | 2009 | 91 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2020 | 208 | 0.040 |
Why?
| | Deglutition Disorders | 1 | 2019 | 122 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2020 | 390 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2020 | 309 | 0.040 |
Why?
| | Self Care | 1 | 2020 | 354 | 0.040 |
Why?
| | Transfection | 2 | 2013 | 866 | 0.040 |
Why?
| | Acute Disease | 1 | 2000 | 917 | 0.040 |
Why?
| | Adenosine Triphosphate | 2 | 2013 | 430 | 0.040 |
Why?
| | Hemoglobins | 1 | 2019 | 313 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2023 | 801 | 0.040 |
Why?
| | Gastroesophageal Reflux | 1 | 2019 | 235 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1090 | 0.030 |
Why?
| | Aged | 2 | 2019 | 19299 | 0.030 |
Why?
| | Phytoplankton | 1 | 2015 | 6 | 0.030 |
Why?
| | Public Health | 1 | 2020 | 439 | 0.030 |
Why?
| | Arctic Regions | 1 | 2015 | 16 | 0.030 |
Why?
| | Aquatic Organisms | 1 | 2015 | 8 | 0.030 |
Why?
| | Patient Transfer | 1 | 2017 | 143 | 0.030 |
Why?
| | Seawater | 1 | 2015 | 21 | 0.030 |
Why?
| | Air | 1 | 2015 | 36 | 0.030 |
Why?
| | Diatoms | 1 | 2015 | 21 | 0.030 |
Why?
| | Freezing | 1 | 2015 | 85 | 0.030 |
Why?
| | Laparoscopy | 1 | 2019 | 400 | 0.030 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 488 | 0.030 |
Why?
| | Comorbidity | 1 | 2019 | 1476 | 0.030 |
Why?
| | Middle Aged | 2 | 2019 | 27084 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2020 | 771 | 0.030 |
Why?
| | Aerosols | 1 | 2015 | 212 | 0.030 |
Why?
| | Organic Chemicals | 1 | 2015 | 128 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4122 | 0.030 |
Why?
| | Phosphorus Isotopes | 1 | 2013 | 8 | 0.030 |
Why?
| | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2013 | 7 | 0.030 |
Why?
| | Biotinylation | 1 | 2013 | 29 | 0.030 |
Why?
| | Transferrin | 1 | 2013 | 40 | 0.030 |
Why?
| | Clathrin | 1 | 2013 | 27 | 0.030 |
Why?
| | Algorithms | 1 | 2000 | 1494 | 0.030 |
Why?
| | Neurotransmitter Agents | 1 | 2013 | 77 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2013 | 154 | 0.030 |
Why?
| | Biophysics | 1 | 2013 | 70 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1773 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2013 | 198 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2013 | 215 | 0.030 |
Why?
| | Hypertension | 1 | 2020 | 1063 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2013 | 3916 | 0.030 |
Why?
| | Protein Transport | 1 | 2013 | 400 | 0.020 |
Why?
| | Glutamic Acid | 1 | 2013 | 213 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 377 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1486 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 546 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1226 | 0.020 |
Why?
| | Protein Conformation | 1 | 2013 | 823 | 0.020 |
Why?
| | Child | 2 | 2017 | 18555 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2013 | 390 | 0.020 |
Why?
| | Tissue Banks | 1 | 2009 | 18 | 0.020 |
Why?
| | Database Management Systems | 1 | 2009 | 48 | 0.020 |
Why?
| | Male | 2 | 2019 | 56128 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2167 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2009 | 110 | 0.020 |
Why?
| | Female | 2 | 2019 | 60086 | 0.020 |
Why?
| | Obesity | 1 | 2020 | 2530 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1919 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2013 | 1319 | 0.020 |
Why?
| | Nodose Ganglion | 1 | 2005 | 6 | 0.020 |
Why?
| | Phorbol 12,13-Dibutyrate | 1 | 2005 | 9 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 9166 | 0.020 |
Why?
| | Polyunsaturated Alkamides | 1 | 2005 | 8 | 0.020 |
Why?
| | Patient Selection | 1 | 2009 | 656 | 0.020 |
Why?
| | Microinjections | 1 | 2005 | 78 | 0.020 |
Why?
| | Magnesium Sulfate | 1 | 2005 | 17 | 0.020 |
Why?
| | Capsaicin | 1 | 2005 | 28 | 0.020 |
Why?
| | Arachidonic Acids | 1 | 2005 | 58 | 0.020 |
Why?
| | Aminobutyrates | 1 | 2005 | 32 | 0.020 |
Why?
| | Bradykinin | 1 | 2005 | 46 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2005 | 129 | 0.020 |
Why?
| | Endocannabinoids | 1 | 2005 | 37 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 2005 | 115 | 0.020 |
Why?
| | Internet | 1 | 2009 | 596 | 0.020 |
Why?
| | Membrane Potentials | 1 | 2005 | 251 | 0.020 |
Why?
| | Rats | 1 | 2013 | 5035 | 0.020 |
Why?
| | Oocytes | 1 | 2005 | 172 | 0.010 |
Why?
| | Databases, Factual | 1 | 2009 | 1149 | 0.010 |
Why?
| | Adolescent | 1 | 2022 | 17955 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 513 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2362 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2019 | 12616 | 0.010 |
Why?
| | Temperature | 1 | 2005 | 590 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 3371 | 0.010 |
Why?
| | Behavior, Animal | 1 | 2005 | 471 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1868 | 0.010 |
Why?
| | Calcium | 1 | 2005 | 1102 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2005 | 2606 | 0.010 |
Why?
| | Animals | 2 | 2013 | 32123 | 0.010 |
Why?
| | Models, Biological | 1 | 2005 | 1647 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2009 | 4670 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2005 | 4769 | 0.010 |
Why?
| | Mice | 1 | 2005 | 15075 | 0.010 |
Why?
|
|
Brooks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|